Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/1060"
| Predicate | Value (sorted: default) |
|---|---|
| rdfs:label | |
| rdf:type | |
| ?:Evidence_dose | |
| ?:Evidence_enzyme_system | |
| ?:Evidence_type | |
| ?:Evidence_value | |
| ?:content |
"route of administration: oral
study duration: "Two 14-day, placebo-controlled, double-blind studies...In Study 1, 37 subjects were randomized to aripiprazole 5 mg, 10 mg, 15 mg, 20 mg, or placebo once daily. In Study 2, 11 subjects were randomized to aripiprazole, titrated from 10 to 30 mg/day, or placebo."
population: adult males
ages: 26 (SD:8.2)
C_max @ 20mg/day: 393ng/mL
393ng/mL X 1g/10^9ng X 1000mL/1L = 0.000393g/L"
|
| dc:creator | |
| dc:date |
"06/19/2009 19:07:53"
|
| rdfs:seeAlso |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl
The resource appears as object in one triple:
{ aripiprazole_maximum_concentration_continuous_value, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1070 }